Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / App Notes / 2017 / DAR Analysis of Antibody-Drug Conjugates

DAR Analysis of Antibody-Drug Conjugates

03/06/2017

Share

Featured Image
Introduction

The antibody drug market has continued to expand in recent years, and antibody drugs held 6 of the top 10 blockbuster drug spots for 2015. The most promising antibody drug candidates for next-generation biopharmaceuticals are ADCs (antibody-drug conjugates). ADCs have a structure in which a cytotoxic drug is chemically bonded to an antibody (IgG).

Because there are numerous binding sites for a low-molecular weight drug on an antibody (Cys, Lys residues, etc.), heterogeneity arises with respect to the number of bonds and binding sites. It is necessary to study in detail the effect that this heterogeneity has on the medicinal effects and safety of ADCs. Since low-molecular drugs are more hydrophobic than monoclonal antibodies, differences in hydrophobicity arise when the number of bonded drug molecules differ. This property can be utilized to determine the drug-to-antibody ratio (DAR) by hydrophobic interaction chromatography (HIC). In this application note an ADC was analyzed using a TSKgel Butyl-NPR column.
Analysis of Unconjugated Trastuzumab and Drug Conjugated Trastuzumab
TSKgel Butyl-NPR, the least hydrophobic of the TSKgel HIC columns, is the best choice for high speed separations with excellent recovery, even for more hydrophobic samples. The ultra-efficient 2.5 micron non-porous particles allow for fast and highly efficient separations. Thus, TSKgel Butyl-NPR columns (4.6 mm ID × 3.5 cm and 10 cm) are ideal for time critical QC analysis or sample-limited applications. An ADC (Trastuzumab-vcMMAE) in which an antineoplastic drug (monomethyl auristatin E, MMAE) is bonded via a linker to Trastuzumab was used. First results using common ammonium sulfate gradient elution conditions showed that the ADC could not be suitably eluted. Hence, an organic solvent (2-propanol) was added to eluent B, and by optimizing the organic solvent concentration, peaks exhibiting different DARs (DAR = 0 to 8) could be well separated (to confirm the DAR, each peak was fractionated and attributed by LC-MS/MS).
>> Download the full Application Note as PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Solvents & Inorganics for accurate, brilliant results
Solvents & Inorganics for accurate, brilliant results

January 9, 2017

Now that the life science business of Merck KGaA, ...

Discovery of Sulfur-Containing Compounds in Broccoli with GC-TOFMS
Discovery of Sulfur-Containing Compounds in Broccoli with GC-TOFMS

January 16, 2017

Analyzing samples of a raw broccoli and a broccoli that was processed to be sold frozen we show the sample-distinguishing differences that occur during food processing...

Aquastar® reagents for brilliant Karl Fischer titration results
Aquastar® reagents for brilliant Karl Fischer titration results

January 23, 2017

Determining the water content of gases, liquids and solids can be achieved with a high degree of accuracy using Karl Fischer titration together with our Aquastar® reagents and standards from Merck...

REACH Polymer Status determined with GPC/SEC
REACH Polymer Status determined with GPC/SEC

January 27, 2017

Polymers are “special substances” in terms of REACH...

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.